CLEO Diagnostics LtdASX: COV

CLEO Screening Test Meets Rigorous Performance Targets

· Issued by CLEO Diagnostics Ltd via ASX

Filed with ASX ·

ASX Announcement CLEO Screening Test Meets Rigorous Performance Targets in First Proof-of- Concept Study Highlights • Prototype Screening Test has met and exceeded its pre-de?ned performance thresholds in its ?rst proof-of-concept study of 247 individuals • In a cohort enriched with 62 Stage I...

View Attachment

6ix is reading this filing.

CLEO Diagnostics Ltd on 6ix

Earlier from CLEO Diagnostics

Later from CLEO Diagnostics

All CLEO Diagnostics news releases